Pfizer share news, announcements and annual reports

NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap

Pfizer Limited · Face value ₹10 · Listed Jul 1966 on BSE, Apr 1999 on NSE

₹3,759.80₹25.40 (0.68%)BSE ₹3,760.40

Share price at the NSE close on 29 Oct 2026. Previous close ₹3,734.40.

29 Oct: open ₹3,749.00, high ₹3,799.00, low ₹3,732.30

52-week range of traded prices to 29 Oct 2026

₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025

Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar

Market cap: ₹17,200 Cr327th largest listed
P/E: 23.40
P/B: 4.09
Dividend yield: 1.99%
ROE: 17.5%
ROCE: 21.0%
Debt to equity: 0.00
Volume, NSE: 13,53757.2% delivered

Pfizer board and management

56 filed, newest first. Page 1 of 2.

Sep 2026
- 18 Sep · Management
  Resignation of Director/KMP/SMP
- 18 Sep · Management
  Resignation of Director/KMP/SMP
- 18 Sep · Management
  Change in Management
Jul 2026
- 27 Jul · Management
  Change in Director(s) of the company.
May 2026
- 12 May · Management
  Appointment of Cost Auditor
Mar 2026
- 31 Mar · Management
  Change in Management
Jan 2026
- 20 Jan · Management
  Change in Management
Dec 2025
- 23 Dec · Management
  Change in Management
Jul 2025
- 2 Jul · Management
  Intimation regarding change in Senior Management Personnel of the Company.
Apr 2025
- 1 Apr · Management
  Intimation regarding change in Senior Management Personnel of the Company.
Jan 2025
- 31 Jan · Management
  Change in Management
Nov 2024
- 14 Nov · Management
  Intimation regarding appointment of Legal Lead (Senior Management Personnel) of the Company.
- 10 Nov · Management
  Change in Director(s) of the company.
- 5 Nov · Management
  Company hereby informs regarding change in Senior Management Personnel.
Jul 2024
- 29 Jul · Management
  Change in Director(s) of the company.
- 10 Jul · Management
  Intimation regarding change in Senior Management Personnel of the Company.
Mar 2024
- 19 Mar · Management
  Change in Auditors of the company.
Feb 2024
- 9 Feb · Management
  Change in Management
Jan 2024
- 22 Jan · Management
  We hereby inform you that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today appointed Mr. Amit Agarwal as the Chief Financial Officer of the Company effective February 26, 2024.Further, upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, also appointed Mr. Amit Agarwal (DIN: 10465938) as an Additional Director (Whole-time Director) of the Company, designated as Executive Director Finance & Chief Financial Officer for a period of 5 years with effect from February 26, 2024. The said appointment shall be subject to the approval of shareholders.Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and List/Comp/14/2018-19 dated June 20, 2018, are enclosed
Nov 2023
- 16 Nov · Management
  Company hereby wishes to inform that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has appointed Ms. Aditi Mehta as Category Lead, Vaccines effective December 1, 2023. Accordingly, Ms. Aditi Mehta shall be a Senior Management Personnel effective the said date.Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed.Request you to please take the above on record.
- 13 Nov · Management
  Company hereby wishes to notify that Mr. Milind Patil has resigned asa Director on the Board with effect from close of business on November 13, 2023, consequentto the expiry of his 5 year term as Executive Director Finance effective the said date and hisensuing retirement from the services of the Company effective November 30, 2023.Pursuant to the above, Mr. Patil shall cease to be a Member of the Corporate Social Responsibility Committee, Risk Management Committee and Board Administrative & ShareTransfer Committee of the Board effective close of business on November 13, 2023.It may be noted that Mr. Patil shall continue to serve as the Chief Financial Officer of theCompany until his retirement on November 30, 2023.Further, the information required in terms of Regulation 30 read with Schedule Ill - Para A (7)of Part A of the SEBI Listing Regulations and SEBI Master Circular bearing Ref. No.SEBI/HO/CFD/ PoD2/CIR/P/2023/120 dated July 11, 2023, is enclosed.The Company records its appreciation for the most valuable contributions rendered byMr. Patil during his tenure.Request you to please take the above on record.
Oct 2023
- 28 Oct · Management
  We refer to our letter dated September 12, 2023, whereby intimation was given that Mr. Samir Kazi has resigned as a Director from the Board of Directors of the Company effective close of business September 12, 2023. (Copy attached)Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, ( SEBI Listing Regulations ), the Company hereby informs that theeffective date of Mr. Samir Kazi s resignation from the employment of the Company will beOctober 31, 2023. Accordingly, Mr. Kazi shall cease to be a Senior Management Personneleffective the said date.Request you to please take the above on record.
Sep 2023
- 12 Sep · Management
  Change in Director(s) of the company.
- 6 Sep · Management
  Company hereby wishes to inform that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has appointed Mr. Chaitanya Nadkarni as India Digital Client Partner Lead effective September 11, 2023. Accordingly, Mr. Chaitanya Nadkarni shall be a Senior Management Personnel effective the said date.Request you to please take the above on record.
Aug 2023
- 18 Aug · Management
  Company hereby wishes to inform you regarding change in Senior Management Personnel of the Company.
Feb 2023
- 9 Feb · Management
  We hereby inform you that Mr. S. Sridhar, Managing Director, who had decided to take early retirement (which was communicated to you vide our letter dated August 10, 2022 copy enclosed) has submitted his resignation with effect from March 31, 2023. The Company places on record its appreciation for the leadership, guidance and support provided by Mr. S. Sridhar during his tenure.
- 9 Feb · Management
  Appointment of Ms Meenakshi Nevatia as Managing Director & CEO of the company w.e.f. April 03, 2023.
May 2022
- 20 May · Management
  This is to inform you that the Statutory Auditors M/s. Walker Chandiok & Co LLP would be completing their term of 5 years at the ensuing Annual General Meeting of the Company. Consequently, based on the recommendation of the Audit Committee of the Company, the Board of Directors of the Company at its meeting held today, i.e., May 20, 2022, recommended appointment of M/s. B S R & Co. LLP, Chartered Accountant (Firm Registration No. 101248W/W-100022) as the Statutory Auditors of the Company. M/s. B S R & Co. LLP will hold office for a period of 5 (five) consecutive years from the conclusion of the ensuing 71st Annual General Meeting of the Company till the conclusion of the 76th Annual General Meeting subject to the approval of the shareholders of the Company.
Feb 2022
- 2 Feb · Management
  Resignation of Mr R A SHAH as Independent Director of the company w.e.f. February 01, 2022.
Feb 2020
- 14 Feb · Management
  Change in Director(s) of the company.
- 14 Feb · Management
  Change in Director(s) of the company.
May 2019
- 29 May · Management
  Change in Director(s) of the company.
Mar 2019
- 8 Mar · Management
  Resignation of Ms Anurita Majumdar as Executive Director of the company w.e.f. March 08, 2019.
- 8 Mar · Management
  Appointment of Ms Meena Ganesh as Non- Executive Independent Director of the company w.e.f. March 08, 2019.
Nov 2018
- 14 Nov · Management
  Appointment of Mr Milind Patil as Executive Director of the company w.e.f. November 14, 2018.
Aug 2018
- 16 Aug · Management
  Appointment of Mr Milind Patil as Chief Financial Officer of the company w.e.f. August 16, 2018.
Mar 2018
- 1 Mar · Management
  Change in Director(s) of the company.
Feb 2018
- 19 Feb · Management
  Change in Director(s) of the company.
May 2017
- 6 May · Management
  Board of Directors of the Company at their Meeting held May 06, 2017 have re-appointed Mr. Vivek Dhariwal (DIN: 02826679) as an Whole-time Director designated as Executive Director, Technical Operations with effect from May 21, 2017 for a term of 5 years. The re-appointment of Mr. Vivek Dhariwal will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.
- 6 May · Management
  Statutory Auditors B S R & Co. LLP would be completing their maximum term permitted under Section 139 of the Companies Act, 2013 and the Rules made thereunder at the ensuing Annual General Meeting of the Company. In view of the same, the Board of Directors of the Company at their meeting held on May 6, 2017, have recommended, the appointment of Walker Chandiok & Co LLP, Chartered Accountants as the statutory auditors of the Company. Walker Chandiok & Co LLP, will hold office for a period of 5 (five) consecutive years from the conclusion of the ensuing Annual General Meeting of the Company till the conclusion of th Annual General Meeting, subject to the approval of shareholders of the Company.
Jan 2017
- 30 Jan · Management
  That the Board of Directors of the Company at their held Meeting held on January 30, 2017 has appointed Mr. Ravi Prakash Bhagavathula as an Additional Director of the Company, designated as an Executive Director, Finance with effect from January 30, 2017 for a period of 5 years.
Nov 2016
- 4 Nov · Management
  Board of Directors of the Company has appointed Dr. Anurita Majumdar (DIN: 05291758) as an Additional Director (Woman Director) of the Company, designated as Executive Director, Medical with effect from November 4, 2016 for a period of 5 years. The appointment of Dr. Anurita Majumdar will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company. Dr. Anurita Majumdar has completed her MBBS from G.S.V.M. Medical College, Kanpur, MD (Radiation Oncology) from J.K. Cancer Institute, Kanpur and Senior Residency (Radiation Oncology) from Tata Memorial Hospital, Mumbai. Dr.Anurita Majumdar joined Pfizer Limited in July 2015 as Senior Director, Medical. Dr.Majumdar has over 15 years of experience in leading clinical research and medical affairs in the pharmaceutical and CRO industry. Prior to joining Pfizer, Dr. Majumdar held position of Director Medical, Regulatory and Quality (supporting India, Sri Lanka, Nepal and Bangladesh) for 7 years at Eli Lilly and Company (India) Private Limited. Dr. Anurita Majumdar does not hold any shares in the Company. None of the Directors are related to Dr. Majumdar.
- 4 Nov · Management
  Ms. Lu Hong has resigned as the Non-executive (Woman) Director from the Board of Pfizer Limited effective November 4, 2016, on account of her relocation to USA for taking up a global role with Pfizer Inc., USA.
Mar 2016
- 18 Mar · Management
  Board of Directors of the Company has appointed Mr. S. Sridhar as the Managing Director of the Company, with effect from March 18, 2016 for a period of 5 years. The appointment of Mr. S. Sridhar will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.
Dec 2015
- 7 Dec · Management
  Board of Directors of the Company has appointed Ms. Lu Hong as an Additional Director (Non-executive Woman Director) of the Company, effective December 4, 2015. The appointment of Ms. Lu Hong will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.
Oct 2015
- 13 Oct · Management
  In June 2015, the Company had announced that Mr. Aijaz Tobaccowalla intends to step down from his position of Managing Director of Pfizer Limited. Pursuant to Clause 30 of the Listing Agreement and in furtherance of letter dated June 5, 2015 (copy attached), Mr. Tobaccowalla has now formally resigned from the said position effective close of business on October 16, 2015. The day-to-day operations of the Company shall be managed by Mr. S. Sridhar, presently the Executive Director, Business Unit and Distribution Head, until such time that Mr. Tobaccowalla's successor is appointed by the Board of Directors.
Sep 2015
- 3 Sep · Management
  Dr. Lakshmi Nadkarni, Executive Director-Human Resources has resigned from the Board of Pfizer Limited effective close of business hours on September 4, 2015.
May 2015
- 12 May · Management
  Mr. S. Sridhar, the Chief Financial Officer of the Company, will be moving to a new role as Business Unit Head effective close of business on May 12, 2015. Consequently, Mr. S. Sridhar will cease to be the Chief Financial Officer of the Company effective the said date. Mr. Ravi Prakash Bhagavathula has been appointed as the Chief Financial Officer of the Company effective May 13, 2015.
May 2013
- 15 May · Management
  Board of Directors of the Company at their Meeting held on May 14, 2013 appointed Mr. S. Sridhar as an Additional Director on the Board of the Company with effect from May 14, 2013. The appointment and remuneration of Mr. S. Sridhar, Whole-time Director will be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
- 15 May · Management
  Board of Directors of the Company at its meeting held on May 14, 2013, has appointed Mr S Sridhar as an Additional Director on the Board of the Company with effect from May 14, 2013.The appointment and remuneration of Mr S Sridhar, Whole-time Director will be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.

Pfizer board and management

Sep 2026

Jul 2026

May 2026

Mar 2026

Jan 2026

Dec 2025

Jul 2025

Apr 2025

Jan 2025

Nov 2024

Jul 2024

Mar 2024

Feb 2024

Jan 2024

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Feb 2023

May 2022

Feb 2022

Feb 2020

May 2019

Mar 2019

Nov 2018

Aug 2018

Mar 2018

Feb 2018

May 2017

Jan 2017

Nov 2016

Mar 2016

Dec 2015

Oct 2015

Sep 2015

May 2015

May 2013